Disease Management and Clinical Outcomes , 1, 136-141
Oral BPC-157 We use the oral formulation primarily when trying to influence gut-specific healing, including: Stomach ulcers Gut wall permeability Crohns disease Ulcerative colitis Celiac disease Post-infectious diarrhea Microscopic colitis We may also consider oral BPC-157 when conditions appear to be influenced by gut inflammation, including psoriasis, rosacea, mood disorders, and cognitive changes
Most people notice initial improvements in skin texture and hydration within 2-3 weeks
This is because telomerase production significantly falls with time
This mechanism of action may be related to the ability of BPC 157 to up-regulate the expression of genes such as Egr1 and Vegfr2, which play important roles in the growth and differentiation of neurons
When combined, these peptides are frequently explored in advanced in-vitro and biochemical model systems to better understand coordinated peptide signaling, multi-pathway cellular regulation, and molecular interactions related to tissue-associated research models